New Jersey AJR 176: Urging FDA to remove restrictions on mifepristone.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-07-02)

State: New Jersey · Session: 219 · Bill: AJR 176

Subjects: PHARMACEUTIC

Sponsors: Vainieri Huttle, Valerie, Speight, Shanique

View New Jersey AJR 176 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.